Skip to main content
T&R Biofab Co., Ltd logo

T&R Biofab Co., Ltd — Investor Relations & Filings

Ticker · 246710 ISIN · KR7246710008 KO Manufacturing
Open in API
Filings indexed 415 across all filing types
Latest filing 2025-07-02 Major Shareholding Noti…
Country KR South Korea
Listing KO 246710

About T&R Biofab Co., Ltd

http://www.tnrbiofab.com/en/

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in the development and commercialization of regenerative medical technologies. The company utilizes its proprietary 3D bioprinting technology to manufacture a range of products. Its primary offerings include 3D-printed, bioresorbable medical scaffolds designed to aid in the regeneration and reconstruction of tissues and organs. Other key business areas encompass bio-surgical solutions, the development of organoids and mini-tissues for research and therapeutic applications, and the use of human induced pluripotent stem cells (hiPSC).

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements (pledges) of major shareholders and special related parties of the company 'T&R Biofab'. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-07-02 Korean
[기재정정]분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '티앤알바이오팹' (T&R Biofab) for the period ending March 31, 2025. It contains detailed financial statements, management discussion, and corporate governance information, which are characteristic of a comprehensive quarterly report. The document also includes a '정정신고' (Correction Report) section at the beginning, which is a standard regulatory procedure for updating previously filed reports. As it contains substantive financial data and analysis for a specific fiscal quarter, it is classified as an Interim/Quarterly Report. Q1 2025
2025-06-16 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사 티앤알바이오팹' covering the period from 2025-01-01 to 2025-03-31. It contains detailed financial statements, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-23 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Provisional Earnings Report' (영업(잠정)실적) for the first quarter of 2025. It provides key financial highlights such as revenue, operating profit, and net income in a table format. This is a standard initial announcement of quarterly financial results, which fits the definition of an Earnings Release (ER). Q1 2025
2025-05-19 Korean
전환가액의조정
Capital/Financing Update Classification · 100% confidence The document is a formal notification regarding the adjustment of the conversion price of convertible bonds (전환가액의 조정) for the company TNR Biofab. It details the specific changes to the conversion price, the number of convertible shares, the rationale (market price increase), and the calculation methodology. This type of filing relates to changes in the company's capital structure and financial instruments, which falls under the 'Capital/Financing Update' category.
2025-05-07 Korean
[기재정정]사업보고서 (2024.12)
Regulatory Filings Classification · 95% confidence The document is a formal 'Correction Report' (정정신고) for an Annual Report (사업보고서) filed by T&R Biofab. It explicitly lists corrections made to financial statements and disclosures in the previously submitted annual report. While it contains financial data, it is a correction filing for a 10-K equivalent (Annual Report). According to the classification rules, this is a regulatory filing related to the correction of a major report, fitting the 'Regulatory Filings' (RNS) category as it is a formal regulatory submission regarding the amendment of a previously filed document. FY 2024
2025-04-29 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.